FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in ...
MedPage Today on MSN
First oral carbapenem approved for complicated UTIs
Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients ...
A new study finds that two subtypes of pathogenic Escherichia coli (E. coli) produce five to 16 times more protective capsular “slime” when Enterococcus faecalis (EF) is present. The finding could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results